VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats
Open Access
- 1 May 2009
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 119 (5) , 1298-1311
Abstract
Idiopathic pulmonary fibrosis (IPF) can lead to the development of secondary pulmonary hypertension (PH) and ultimately death. Despite this known association, the precise mechanism of disease remains unknown. Using a rat model of IPF, we explored the role of the proangiogenic and antiapoptotic growth factor VEGF in the vascular remodeling that underlies PH. In this model, adenoviral delivery of active TGF-β1 induces pulmonary arterial remodeling, loss of the microvasculature in fibrotic areas, and increased pulmonary arterial pressure (PAP). Immunohistochemistry and mRNA analysis revealed decreased levels of VEGF and its receptor, which were inversely correlated with PAP and endothelial cell apoptosis in both the micro- and macrovasculature. Treatment of IPF rats with adenoviral delivery of VEGF resulted in reduced endothelial apoptosis, increased vascularization, and improved PAP due to reduced remodeling but worsened PF. These data show that experimental pulmonary fibrosis (PF) leads to loss of the microvasculature through increased apoptosis and to remodeling of the pulmonary arteries, with both processes resulting in PH. As administration of VEGF ameliorated the PH in this model but concomitantly aggravated the fibrogenic process, VEGF-based therapies should be used with caution.Keywords
This publication has 60 references indexed in Scilit:
- Role of the TGF-β/Alk5 Signaling Pathway in Monocrotaline-induced Pulmonary HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2008
- The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis?The International Journal of Biochemistry & Cell Biology, 2008
- The role of CXC chemokines in pulmonary fibrosisJournal of Clinical Investigation, 2007
- Bone Morphogenetic Protein-4 Inhibitor Gremlin Is Overexpressed in Idiopathic Pulmonary FibrosisThe American Journal of Pathology, 2006
- HIF-Dependent Hematopoietic Factors Regulate the Development of the Embryonic VasculatureDevelopmental Cell, 2006
- Transforming growth factor-β1 induces Nox4 NAD(P)H oxidase and reactive oxygen species-dependent proliferation in human pulmonary artery smooth muscle cellsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2006
- Gene transfer of vascular endothelial growth factor reduces bleomycin‐induced pulmonary hypertension in immature rabbitsPediatrics International, 2005
- Angiogenic cytokines in patients with idiopathic interstitial pneumoniaThorax, 2004
- Endothelial Dysfunction in Pulmonary HypertensionCirculation, 2004
- Vascular Endothelial Growth Factor in Pulmonary HypertensionAnnals of the New York Academy of Sciences, 1996